Literature DB >> 20926325

Body composition analysis in late-onset Pompe disease.

G K Papadimas1, G Terzis, S Methenitis, K Spengos, C Papadopoulos, S Vassilopoulou, S Kavouras, H Michelakakis, P Manta.   

Abstract

Pompe disease is an inherited metabolic disorder caused by α-glycosidase deficiency. The adult onset form is mainly characterized by progressive proximal muscle weakness and respiratory dysfunction. The aim of the present study is to evaluate body composition in adult patients before and after enzyme replacement therapy (ERT). Body composition was examined at baseline by means of dual x-ray absorptiometry (DXA) in nine adult patients and after different time periods in six of them who received ERT. Total BMD (bone mineral density) was initially mildly decreased in two patients, while femoral neck BMD was decreased in five patients. On the other hand fat mass was increased in the majority of patients, while body mass index (BMI) was high in four. ERT administration did not seem to induce obvious BMD changes in any patient. Conclusively, the greater femoral neck BMD involvement may be attributed to the lower mechanical load applied by the selectively weakened muscles, whereas the increased fat mass may be the result of metabolic and nutritional derangement. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20926325     DOI: 10.1016/j.ymgme.2010.09.002

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  14 in total

Review 1.  Molecular genetics of Pompe disease: a comprehensive overview.

Authors:  Paolo Peruzzo; Eleonora Pavan; Andrea Dardis
Journal:  Ann Transl Med       Date:  2019-07

Review 2.  Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.

Authors:  Antonio Toscano; Carmelo Rodolico; Olimpia Musumeci
Journal:  Ann Transl Med       Date:  2019-07

Review 3.  Nutrition and exercise in Pompe disease.

Authors:  Mark A Tarnopolsky; Mats I Nilsson
Journal:  Ann Transl Med       Date:  2019-07

Review 4.  Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature.

Authors:  Gauthier Remiche; Dario Ronchi; Francesca Magri; Costanza Lamperti; Andreina Bordoni; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

Review 5.  Non-muscle involvement in late-onset glycogenosis II.

Authors:  Massimiliano Filosto; Alice Todeschini; Maria Sofia Cotelli; Valentina Vielmi; Fabrizio Rinaldi; Silvia Rota; Mauro Scarpelli; Alessandro Padovani
Journal:  Acta Myol       Date:  2013-10

6.  Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group.

Authors:  Fatma Al Jasmi; Mohammed Al Jumah; Fatimah Alqarni; Nouriya Al-Sanna'a; Fawziah Al-Sharif; Saeed Bohlega; Edward J Cupler; Waseem Fathalla; Mohamed A Hamdan; Nawal Makhseed; Shahriar Nafissi; Yalda Nilipour; Laila Selim; Nuri Shembesh; Rawda Sunbul; Seyed Hassan Tonekaboni
Journal:  BMC Neurol       Date:  2015-10-15       Impact factor: 2.474

7.  Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - A cross sectional survey.

Authors:  F Danckworth; N Karabul; A Posa; F Hanisch
Journal:  Mol Genet Metab Rep       Date:  2014-02-11

8.  Bone density in patients with late onset Pompe disease.

Authors:  George Papadimas; Gerassimos Terzis; Constantinos Papadopoulos; Anna Areovimata; Konstantinos Spengos; Stavros Kavouras; Panagiota Manta
Journal:  Int J Endocrinol Metab       Date:  2012-09-30

9.  Distinct disease phenotypes linked to different combinations of GAA mutations in a large late-onset GSDII sibship.

Authors:  Simone Sampaolo; Teresa Esposito; Olimpia Farina; Daniela Formicola; Daria Diodato; Fernando Gianfrancesco; Federica Cipullo; Gaetana Cremone; Mario Cirillo; Luca Del Viscovo; Antonio Toscano; Corrado Angelini; Giuseppe Di Iorio
Journal:  Orphanet J Rare Dis       Date:  2013-10-10       Impact factor: 4.123

Review 10.  Current Applications and Selected Technical Details of Dual-Energy X-Ray Absorptiometry.

Authors:  Piotr Sawicki; Marek Tałałaj; Katarzyna Życińska; Wojciech S Zgliczyński; Waldemar Wierzba
Journal:  Med Sci Monit       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.